Purchase Order HT001424P0286
Award Date
9/27/24
Potential Completion Date
9/26/25
Potential Value
$31K
Federal Agency
Defense Health Agency
Awardee
LGC Clinical Diagnostics Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Italy
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency, an agency of the Department of Defense, awarded a $25,538 purchase order to LGC Clinical Diagnostics Inc.'s Clinical Diagnostics Division for the MAINE STANDARDFY23V-402VT VALIDATE CM2 contract. Under this firm fixed price contract, LGC Clinical Diagnostics will provide clinical diagnostic services from its location in Italy to validate the agency's CM2 program. No subcontractors or set aside designations were identified. The contract runs from July 2024 through May...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price purchase order to LGC Clinical Diagnostics Inc. for reference materials in the amount of one thousand seven hundred eight dollars and seventy-one cents ($1,708.71). The period of performance is through September 1, 2022. No set aside designation was used for this award. LGC Clinical Diagnostics Inc. will provide the reference materials in support of COVID-19 response efforts. As a foreign owned, for-profit...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical laboratory products and diagnostics. The contract, valued at $77,990.25, is for the delivery of LAB PANELS with a period of performance through September 29, 2023. LGC Clinical Diagnostics has previously provided a variety of diagnostic testing services, validation testing, laboratory panels, control...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to LGC Clinical Diagnostics Inc. for $24,778.00. The contract is for the delivery of SeraCare bioservices, which include quality control tools, reference materials, controls, reagents, and biological materials to support clinical diagnostics, disease prevention, and health promotion initiatives. LGC Clinical Diagnostics, a foreign-owned, for-profit manufacturer, has been awarded...
This is a $13,459.86 firm fixed-price purchase order awarded to LGC Clinical Diagnostics Inc., a foreign-owned, for-profit manufacturer of clinical diagnostics products, by the National Institutes of Health (NIH) Clinical Center. The order is for 25-004737-SEROLOGICAL ASSAYS, with an ultimate completion date of April 14, 2025. LGC Clinical Diagnostics has previously received numerous federal contracts, primarily purchase orders, to provide a variety of diagnostic testing services, validation...
This is a federal contract award from the Defense Health Agency (DHA) to Diasorin Molecular, LLC, a foreign-owned, for-profit medical diagnostics manufacturer. The $31,902.78 firm fixed price purchase order is for the LIAISON MDX Service, which supports the DHA's healthcare operations. The contract has an ultimate completion date of January 22, 2027 and was awarded on January 23, 2023 without a set-aside designation. Diasorin Molecular, LLC is a specialized provider of molecular diagnostic...
Laboratory Corporation of America has been awarded a $2.25 million firm fixed price delivery order against an unspecified government-wide acquisition contract (GWAC) by the Defense Health Agency to provide clinical reference laboratory testing services. The prime contractor will perform the testing out of its Portsmouth, Virginia laboratory location from April 1, 2021 through September 30, 2021. No subcontractors or set aside designations were identified. The Defense Health Agency is a joint,...
This is a federal purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to LGC Clinical Diagnostics Inc., a foreign-owned for-profit manufacturer of clinical diagnostic products. The contract, valued at $21,556.49, is for the provision of HIV Performance Panels, which are quality control tools used in clinical laboratories. The contract has a completion date of September 30, 2019 and a firm fixed price pricing type. This...
This federal contract award is for reference laboratory testing services to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The $4,995.12 firm-fixed-price delivery order was awarded to Laboratory Corporation of America (LabCorp), a leading global life sciences company with extensive experience providing diagnostic services to government agencies. The contract has a period of performance through March 31, 2025 and is not set aside for small businesses....
Laboratory Corporation of America has been awarded a $3 million firm fixed price delivery order against an unspecified contract vehicle to provide clinical reference laboratory testing services to the Defense Health Agency of the Department of Defense. The prime contractor, headquartered in San Diego, California, will perform the work from October 2020 through March 2021. No subcontractors or set aside designations are indicated. The Defense Health Agency manages the Military Health System for...